Who
Shannon Morris
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Erasca.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $602K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Apr 2023
- Last trade
- 4 Mar 2026
- Last filed
- 6 Mar 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Mar 2026filed 6 Mar 2026 | ERAS ErascaBiotechnology | SEC FORM 4 Code M | $34K20,000 at $1.70 | filing |
| 4 Mar 2026filed 6 Mar 2026 | ERAS ErascaBiotechnology | SEC FORM 4 Sold | $301K20,000 at $15.04 | filing |
| 4 Mar 2026filed 6 Mar 2026 | ERAS ErascaBiotechnology | SEC FORM 4 Code M | $34K20,000 at $1.70 | filing |
| 4 Mar 2026filed 6 Mar 2026 | ERAS ErascaBiotechnology | SEC FORM 4 Sold | $301K20,000 at $15.04 | filing |
| 29 Jan 2026filed 30 Jan 2026 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —625,000 at $0.00 | filing |
| 29 Jan 2026filed 30 Jan 2026 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —625,000 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2026 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2026 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 3 Feb 2025filed 5 Feb 2025 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —780,000 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —137,142 at $0.00 | filing |
| 5 Feb 2024filed 7 Feb 2024 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —535,800 at $0.00 | filing |
| 10 Apr 2023filed 13 Apr 2023 | ERAS Erascaoption or derivative · Biotechnology | SEC FORM 4 Code A | —375,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.